D-0259-2026 Class II Ongoing
FDA drug recall D-0259-2026 was initiated by Alvogen, Inc on December 31, 2025 and is designated Class II. Reason for recall: Product Mix-Up: A single bottle of this lot was reported by a pharmacy to contain 88 mcg tablets instead of 150 mcg tablets. The recall status is ongoing.
Recall Details
- Product Type
- Drugs
- Report Date
- January 21, 2026
- Initiation Date
- December 31, 2025
- Termination Date
- N/A
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
Product Description
Levothyroxine Sodium Tablets, USP, Thyro-Tabs, 150mcg, 1000 Tablets, Rx only, Manufactured by: LLOYD, Inc., Shenandoah, IA, 51601 USA, Distributed by: Alvogen, Inc., Pine Brook, NJ 07058 USA, NDC: 47781-662-10.
Reason for Recall
Product Mix-Up: A single bottle of this lot was reported by a pharmacy to contain 88 mcg tablets instead of 150 mcg tablets.
Distribution Pattern
US Nationwide.
Code Information
Lot # MHA21825, Exp Date: December 31, 2027